Literature DB >> 22807967

Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia associated with neuroendocrine carcinoma: A case report.

Hee Jun Kim1, In Ho Moh, Hana Yoo, Seungyeon Son, DA Hye Jung, Hun Gu Lee, Dong Hee Han, Jae Hyun Park, Hyeong Su Kim, Jung Han Kim.   

Abstract

Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia (EDTA-PTCP) is an in vitro phenomenon of EDTA-induced platelet aggregation at room temperature. This phenomenon consists of platelet clumping due to anti-platelet antibodies in blood anticoagulated with EDTA. It has been reported in patients with various diseases, including sepsis, multiple myeloma, acute myocardial infarction and breast cancer. Since unrecognized EDTA-PTCP may lead to inappropriate treatment, it should always be considered as a possible cause in patients with low platelet counts. This study identified a case of transient EDTA-PTCP in a patient with neuroendocrine carcinoma of the stomach. In the present study, a 50-year-old male presented with epigastric pain and a weight loss of 15 kg. The patient presented with EDTA-PTCP and was diagnosed with neuroendocrine carcinoma of the stomach. Following systemic chemotherapy, the tumor showed a marked regression and the EDTA-PTCP disappeared. The mechanism by which this occurred is not clear but an association of EDTA-PTCP with neuroendocrine carcinoma is strongly suggested.

Entities:  

Year:  2012        PMID: 22807967      PMCID: PMC3398370          DOI: 10.3892/ol.2012.675

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  15 in total

1.  Accurate platelet counting in an insidious case of pseudothrombocytopenia.

Authors:  A J Lombarts; J J Zijlstra; R H Peters; C G Thomasson; P F Franck
Journal:  Clin Chem Lab Med       Date:  1999 Nov-Dec       Impact factor: 3.694

2.  Pseudothrombocytopenia associated with multiple myeloma.

Authors:  Bryan W Reed; Ronald S Go
Journal:  Mayo Clin Proc       Date:  2006-07       Impact factor: 7.616

Review 3.  EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature.

Authors:  N Berkman; Y Michaeli; R Or; A Eldor
Journal:  Am J Hematol       Date:  1991-03       Impact factor: 10.047

Review 4.  Guillain-Barré syndrome and ethylene diamine tetraacetic acid-dependent pseudothrombocytopenia associated with mumps.

Authors:  A Sawazaki; N Nakamura; H Jyokaji; S Minami; S Nakamura; T Matsuda
Journal:  Intern Med       Date:  1996-12       Impact factor: 1.271

5.  Screening for EDTA-dependent deviations in platelet counts and abnormalities in platelet distribution histograms in pseudothrombocytopenia.

Authors:  P C Bartels; M Schoorl; A J Lombarts
Journal:  Scand J Clin Lab Invest       Date:  1997-11       Impact factor: 1.713

6.  [An adult patient with EDTA-dependent pseudothrombocytopenia due to rubella virus infection].

Authors:  Y Saburi; M Aragaki; S Matsui; T Ishii; S Miyazaki; H Nagai; H Kikuch; T Tashiro; M Nasu
Journal:  Kansenshogaku Zasshi       Date:  1993-06

7.  Pseudoleukocytosis due to EDTA-induced platelet clumping.

Authors:  R A Savage
Journal:  Am J Clin Pathol       Date:  1984-03       Impact factor: 2.493

8.  Transient EDTA-dependent pseudothrombocytopenia in a patient with sepsis.

Authors:  M Mori; H Kudo; S Yoshitake; K Ito; C Shinguu; T Noguchi
Journal:  Intensive Care Med       Date:  2000-02       Impact factor: 17.440

9.  Occult breast cancer with EDTA-dependent pseudothrombocytopenia -a case report-.

Authors:  Hajime Abe; Tomoharu Shimizu; Hirotomi Cho; Yoshihiro Kubota; Tomoko Umeda; Yoshimasa Kurumi; Tohru Tani
Journal:  Gan To Kagaku Ryoho       Date:  2010-05

10.  An unusual cause of mismanagement in an acute myocardial infarction case: pseudothrombocytopenia.

Authors:  Tolga H Kocum; Tuna M Katircibasi; Alpay T Sezgin; Hakan Atalay
Journal:  Am J Emerg Med       Date:  2008-07       Impact factor: 2.469

View more
  6 in total

1.  EDTA-induced pseudothrombocytopenia in association with bladder cancer.

Authors:  Cem Sahin; Ismail Kırlı; Hamdi Sozen; Tugba Dibektas Canbek
Journal:  BMJ Case Rep       Date:  2014-06-20

2.  Poorer prognosis with ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia: a single-center case-control study.

Authors:  Naoko Ohashi-Fukuda; Ryota Inokuchi; Hajime Sato; Kensuke Nakamura; Masao Iwagami; Tomoki Wada; Masahiro Jona; Takashi Hisasue; Susumu Nakajima; Naoki Yahagi
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

3.  An Episode of Pseudothrombocytopenia during Pembrolizumab Therapy in NSCLC Patient.

Authors:  Kinga Krukowska; Robert Kieszko; Katarzyna Kurek; Izabela Chmielewska; Paweł Krawczyk; Janusz Milanowski
Journal:  Case Rep Oncol Med       Date:  2020-05-08

Review 4.  Pseudothrombocytopenia-A Review on Causes, Occurrence and Clinical Implications.

Authors:  Benjamin Lardinois; Julien Favresse; Bernard Chatelain; Giuseppe Lippi; François Mullier
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

5.  Chronic subdural hematoma in elderly patient with EDTA-dependent pseudothrombocytopenia recently treated with aspirin and warfarin: case report.

Authors:  Masato Tosa; Hiroshi Fujita; Yumiko Ishihama; Shigeko Nishimura; Takafumi Ide
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-01-28       Impact factor: 1.742

6.  Correction of spurious low platelet counts by optical fluorescence platelet counting of BC-6800 hematology analyzer in EDTA-dependent pseudo thrombocytopenia patients.

Authors:  Yejiang Bao; Jia Wang; Anjun Wang; Jia Bian; Yuan Jin
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.